MedPath

The Effects of Mindfulness-Based Stress Reduction on Attention and Pain-related Symptoms in Chronic Pain Patients

Not Applicable
Completed
Conditions
Pain
Interventions
Behavioral: Mindfulness-Based Stress Reduction
Registration Number
NCT01487473
Lead Sponsor
York University
Brief Summary

The main purpose of this study is to determine the degree to which Mindfulness-Based Stress Reduction, a group-based psychological therapy that includes mindfulness meditation exercises, reduces depression, anxiety, stress, pain intensity, and interference of pain with daily life among adult chronic pain patients.

The second purpose is to examine the role of attention in improving psychological and physical health for chronic pain patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • Adult chronic pain patients who are proficient in English
  • Capable of interacting with others in a group setting
  • Capable of working with a computer
Exclusion Criteria
  • Alcohol or drug abuse (past history is acceptable as long as their situation has been stable for at least 3 months)
  • Psychiatric psychosis (patients who have a past history of schizophrenia are eligible as long as they are currently stable)
  • Current major depressive disorder
  • Current severe social phobia
  • At immediate risk for suicide
  • Cerebral lesions or tumors (unless medically and cognitively stable)
  • Neurological disease
  • Medically unstable
  • Cognitively unstable
  • Previously participated in a mindfulness meditation program

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Mindfulness-Based Stress ReductionMindfulness-Based Stress Reduction-
Primary Outcome Measures
NameTimeMethod
Pain disability and AttentionBaseline, immediately following treatment, and at 3 months follow up

Change in pain disability assessed by the Pain Disability Index (PDI).

Change in attention assessed by an adapted version of the Change Blindness Task

Secondary Outcome Measures
NameTimeMethod
StressBaseline, immediately following treatment, and at 3 months follow up

Change in stress assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)

AcceptanceBaseline, immediately following treatment, and at 3 months follow up

Change in acceptance assessed by the Chronic Pain Acceptance Questionnaire (CPAQ)

Pain IntensityBaseline, immediately following treatment, and at 3 months follow up

Change in pain intensity assessed by the Short-form McGill Pain Questionnaire (SF-MPQ-2).

DepressionBaseline, immediately following treatment, and at 3 months follow up

Change in depression assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)

AnxietyBaseline, immediately following treatment, and at 3 months follow up

Change in anxiety assessed by the Depression, Anxiety, and Stress Scale 21 (DASS-21)

MindfulnessBaseline, immediately following treatment, and at 3 months follow up

Change in mindfulness assessed by the Five Facet Mindfulness Questionnaire (FFMQ) and Mindful Attention Awareness Scale (MAAS)

Trial Locations

Locations (1)

Mount Sinai Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath